Stock listing

LUXSE:CIPLA Cipla Ltd Action

Luxembourg listing (LUXSE) of Cipla Ltd · home listing NSE:CIPLA

Follow Cipla Ltd into a list and get an email when it puts out news.

Home listing price · NSE:CIPLA

₹1,415.00 INR -2.00 (-0.1%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NSE:CIPLA

Past year -7.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₹1,401.20 – ₹1,428.00 INRNov 20, 2026
Volume
1.48M sharesNov 20, 2026
Market cap
₹1.14T INRAt the close on Nov 20, 2026 · price × 807.9M shares outstanding
52-week range
₹1,165.70 – ₹1,539.70 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₹1.54B INRMedian day 1.01M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Cipla Ltd logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NSE:CIPLA · Home₹1,415.00 INR-2.00 (-0.1%)1,484,426₹1,418.50₹1,428.00₹1,401.20₹1,417.00Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:CIPLA · INR, adjusted for splits

DayCloseChange%OpenHighLowVolume
₹1,415.00-2.00-0.1%₹1,418.50₹1,428.00₹1,401.201,484,426
₹1,417.00+29.00+2.1%₹1,390.00₹1,435.00₹1,381.302,909,024
₹1,388.00-6.50-0.5%₹1,390.00₹1,399.40₹1,383.001,017,376
₹1,394.50+2.70+0.2%₹1,393.00₹1,406.00₹1,389.001,248,691
₹1,391.80-16.50-1.2%₹1,407.00₹1,418.70₹1,391.801,022,855
₹1,408.30-11.60-0.8%₹1,413.60₹1,420.00₹1,399.501,683,740
₹1,419.90+16.10+1.1%₹1,415.80₹1,420.20₹1,406.101,723,204
₹1,403.80-7.20-0.5%₹1,408.00₹1,421.40₹1,397.501,706,347
₹1,411.00+6.90+0.5%₹1,387.00₹1,411.00₹1,382.001,567,019
₹1,404.10+2.10+0.1%₹1,405.00₹1,408.00₹1,390.201,226,346
₹1,402.00+5.10+0.4%₹1,391.70₹1,402.00₹1,386.001,322,399
₹1,396.90+9.90+0.7%₹1,382.20₹1,396.90₹1,370.501,723,192
₹1,387.00+8.10+0.6%₹1,383.00₹1,391.00₹1,364.601,377,336
₹1,378.90+20.90+1.5%₹1,362.00₹1,381.70₹1,357.001,436,661
₹1,358.00-7.60-0.6%₹1,357.70₹1,372.50₹1,347.001,141,230
₹1,365.60+15.60+1.2%₹1,335.20₹1,368.20₹1,327.10997,121
₹1,350.00-5.00-0.4%₹1,352.10₹1,372.70₹1,319.004,078,811
₹1,355.00+17.00+1.3%₹1,336.60₹1,360.00₹1,330.001,548,428
₹1,338.00+7.10+0.5%₹1,332.40₹1,338.00₹1,314.101,323,900
₹1,330.90+16.90+1.3%₹1,302.00₹1,330.90₹1,296.40638,943
₹1,314.00-10.10-0.8%₹1,324.10₹1,337.50₹1,308.301,238,869
₹1,324.10-1.00-0.1%₹1,322.00₹1,339.00₹1,321.601,387,215
₹1,325.10-2.90-0.2%₹1,335.00₹1,337.50₹1,315.10850,284
₹1,328.00+13.40+1.0%₹1,311.60₹1,336.40₹1,310.601,371,747
₹1,314.60-15.00-1.1%₹1,333.30₹1,333.30₹1,302.70994,166
₹1,329.60+18.30+1.4%₹1,315.00₹1,329.60₹1,303.00478,066
₹1,311.30+10.30+0.8%₹1,307.40₹1,317.40₹1,300.20666,122
₹1,301.00-5.80-0.4%₹1,310.50₹1,316.40₹1,295.30653,621
₹1,306.80-20.40-1.5%₹1,323.20₹1,334.20₹1,292.00551,708
₹1,327.20-13.00-1.0%₹1,338.50₹1,351.00₹1,324.70847,901
₹1,340.20+4.70+0.4%₹1,335.00₹1,344.90₹1,323.20575,696
₹1,335.50-8.50-0.6%₹1,334.30₹1,337.70₹1,321.001,084,209
₹1,344.00-2.00-0.1%₹1,349.10₹1,359.40₹1,333.40921,789
₹1,346.00-33.30-2.4%₹1,383.00₹1,384.00₹1,346.001,063,964
₹1,379.30-4.40-0.3%₹1,390.00₹1,401.80₹1,376.201,479,526
₹1,383.70-16.00-1.1%₹1,399.70₹1,405.00₹1,380.50711,020
₹1,399.70+0.70+0.1%₹1,402.90₹1,421.00₹1,388.401,166,527
₹1,399.00+16.00+1.2%₹1,375.00₹1,419.00₹1,364.601,580,784
₹1,383.00-1.10-0.1%₹1,382.40₹1,387.00₹1,371.80651,221
₹1,384.10-2.00-0.1%₹1,386.30₹1,388.70₹1,364.50767,139
₹1,386.10-8.40-0.6%₹1,383.20₹1,405.20₹1,378.30895,131
₹1,394.50+18.20+1.3%₹1,371.70₹1,394.50₹1,371.701,386,584
₹1,376.30+18.30+1.3%₹1,362.50₹1,385.00₹1,351.60730,653
₹1,358.00+7.00+0.5%₹1,351.00₹1,363.70₹1,344.30911,572
₹1,351.00-15.00-1.1%₹1,355.00₹1,362.70₹1,347.701,225,305
₹1,366.00-7.30-0.5%₹1,373.00₹1,373.00₹1,347.701,681,155
₹1,373.30+10.20+0.7%₹1,366.80₹1,380.00₹1,363.10826,221
₹1,363.10-20.90-1.5%₹1,380.00₹1,388.70₹1,363.10818,773
₹1,384.00-11.00-0.8%₹1,393.40₹1,398.40₹1,377.20728,795
₹1,395.00+10.00+0.7%₹1,380.00₹1,395.70₹1,376.80606,497
₹1,385.00-9.70-0.7%₹1,397.70₹1,399.10₹1,375.501,326,180
₹1,394.70-18.10-1.3%₹1,414.00₹1,415.40₹1,389.40549,749
₹1,412.80-10.20-0.7%₹1,414.00₹1,417.00₹1,401.20578,260
₹1,423.00+13.80+1.0%₹1,420.90₹1,425.70₹1,406.50880,100
₹1,409.20-14.30-1.0%₹1,418.00₹1,426.10₹1,409.20977,929
₹1,423.50+3.50+0.2%₹1,420.00₹1,423.90₹1,409.10377,976
₹1,420.00+17.30+1.2%₹1,405.00₹1,420.00₹1,402.10533,212
₹1,402.70-19.30-1.4%₹1,413.50₹1,419.40₹1,401.10915,493
₹1,422.00-15.90-1.1%₹1,435.90₹1,435.90₹1,411.10799,235
₹1,437.90+5.70+0.4%₹1,428.00₹1,442.30₹1,410.301,220,646
₹1,432.20-5.80-0.4%₹1,433.40₹1,443.60₹1,408.60728,275
₹1,438.00+16.00+1.1%₹1,430.00₹1,439.40₹1,427.50327,752

Splits

3 splits since 1999 · NSE:CIPLA · every price before a split is adjusted for it

DayRatioWhat
5-for-2Split
5-for-1Split
3-for-1Split
Ticker
LUXSE:CIPLA
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
LUXSE
Currency
USD

What changed lately

Latest news

All Cipla Ltd news

Cipla Ltd on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
13 in the last 12 months · 93 in all · newest Oct 27, 2026 · oldest 2020
Decks
81 decks · latest Oct 27, 2026

Where Cipla Ltd is listed

ListingExchangeCountryCurrency
NSE:CIPLA · Home listingNSEIndiaINR
BSE:CIPLABSEIndiaINR
LUXSE:CIPLA · This pageLUXSELuxembourgUSD
Turquoise:CIPLGXTurquoiseUnited KingdomUSD

Valuation

P/E 39.5× against a median of 41.4×: 5th lowest of 10 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
₹1.04T INR
P/E
39.5×
EV/sales
3.7×
EV/EBITDA
21.6×
Price/book
3.2×
Gross margin
57.1%
Operating margin
12.6%
Net margin
10.4%
Debt to equity
0.0×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Cipla Ltd · NSE:CIPLAUS$12.34BUS$11.26B39.5×3.7×21.6×3.2×10.4%0.0×n/a
Yunnan Baiyao Group Co. Ltd. Class A · SZSE:000538US$15.07BUS$13.10B19.4×2.0×n/a2.5×12.2%0.0×n/a
Jazz Pharmaceuticals plc · NASDAQ:JAZZUS$14.95BUS$18.48B72.6×3.9×n/a3.6×4.4%1.3×0.64
Ipsen SA · EURONEXT:IPNUS$14.62BUS$13.51B30.0×3.4×11.2×2.8×12.1%0.2×n/a
Laurus Labs Ltd. · NSE:LAURUSLABSUS$13.38BUS$13.66B92.5×16.2×53.2×20.5×17.1%0.4×n/a
Zydus Lifesciences Limited · NSE:ZYDUSLIFEUS$12.92BUS$13.86B28.6×4.2×17.9×4.3×13.8%0.5×n/a
Elanco Animal Health Incorporated · NYSE:ELANUS$12.87BUS$15.85Bn/a3.1×13.1×1.9×−2.9%0.5×1.20
Dr. Reddy's Laboratories Ltd. · NSE:DRREDDYUS$12.50BUS$12.45B41.4×3.5×22.6×3.0×8.5%0.2×n/a
Mankind Pharma Ltd. · NSE:MANKINDUS$11.88BUS$12.18B49.1×7.3×27.7×6.3×14.6%0.3×n/a
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A · SSE:600436US$11.62BUS$11.29B58.9×9.5×n/a5.5×16.7%0.0×n/a
Aurobindo Pharma Ltd · NSE:AUROPHARMAUS$11.17BUS$11.02B25.9×2.8×13.4×2.6×10.8%0.2×n/a
Median of the othersUS$12.89BUS$13.31B41.4×3.7×17.9×3.3×12.1%0.3×0.92

Forecasts

Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.

Price target
1507.31 INR · Analysts' mean
EPS, year to Mar 2027
48.70 · 35 analysts
Revenue, year to Mar 2027
305.6B · 35 analysts

Team and board

Officers

OfficerRole
Achin GuptaManaging Director & Global Chief Executive Officer
Paul MillerCEO Cipla South Africa & Regional Head Africa and Access
Shivam PuriCEO - One India Business
Swapn MalpaniCEO – Emerging Markets and Europe
Dinesh JainGlobal Chief Financial Officer
Meera VanjariChief General Counsel (Global)
Arun KakatkarGlobal Chief People Officer
Jaideep GogtayGlobal Chief Medical Officer
Marc FalkinCEO - North America
Prabhakaran NairGlobal Chief Manufacturing Officer
Sai MungaraGlobal Head Supply Chain
Sneha HiranandaniChief Information Officer
Sushrut KulkarniGlobal Chief- Integrated Product Development (IPD)

Board

DirectorRole
Abhijit JoshiNon-Executive Director
Adil ZainulbhaiNon-Executive Director
Balram BhargavaIndependent Director
Mandar VaidyaIndependent Director
Maya HariIndependent Director
Rashmi JoshiIndependent Director

Events

Next results
Jan 21, 2027 (expected)
QuarterResultsShare move
Q2 2027Oct 27, 2026 · Before open−0.4%
Q1 2027Jul 23, 2026 · Before open−1.5%
Q4 2026May 13, 2026 · Before open+2.8%
Q3 2026Jan 23, 2026 · Before open−3.8%
Q2 2026Oct 30, 2025 · Before open−2.5%
Q1 2026Jul 25, 2025 · Before open+3.3%
Q4 2025May 13, 2025 · Before open+0.8%
Q3 2025Jan 28, 2025 · Before open+2.2%
Q2 2025Oct 29, 2024 · Before open−1.9%
Q1 2025Jul 26, 2024 · Before open+5.6%
All 20 quarters
QuarterResultsShare move
Q4 2024May 10, 2024 · Before open−1.9%
Q3 2024Jan 22, 2024 · Before open+7.2%
Q2 2024Oct 27, 2023 · Before open+2.1%
Q1 2024Jul 26, 2023 · Before open+2.3%
Q4 2023May 12, 2023 · After close−1.1%
Q3 2023Jan 25, 2023 · Before open−2.1%
Q2 2023Nov 4, 2022 · Before open−1.6%
Q1 2023Jul 29, 2022 · Before open+1.1%
Q4 2022May 10, 2022 · Before open−1.2%
Q3 2022Jan 25, 2022 · Before open+1.1%

Open Events

Decks

DeckKindSlidesDate
Q2 FY27 Earnings PresentationEarnings17 slidesOct 27, 2026
Q1 FY27 Earnings PresentationEarnings15 slidesJul 23, 2026
Q4 FY26 Earnings PresentationEarnings22 slidesMay 13, 2026
Q3 FY26 Earnings PresentationEarnings17 slidesJan 23, 2026
Q2 FY26 Earnings PresentationEarnings18 slidesOct 30, 2025
Q2 FY2026 Earnings PresentationEarnings17 slidesOct 30, 2025
Q1 FY26 Earnings PresentationEarnings17 slidesJul 25, 2025
Q1 FY2026 Earnings PresentationEarnings16 slidesJul 25, 2025
Shareholder Meeting (July 2025)Shareholder meeting18 slidesJul 16, 2025
Q4 FY25 Earnings PresentationEarnings23 slidesMay 13, 2025
Show 50 decks
DeckKindSlidesDate
Kotak Chasing Growth Conference 2025Conference24 slidesFeb 18, 2025
Q3 FY2025 Earnings PresentationEarnings17 slidesJan 28, 2025
Q2 FY2025 Earnings PresentationEarnings16 slidesOct 29, 2024
Shareholder Meeting (August 2024)Shareholder meeting8 slidesAugust 2024
Q1 FY2025 Earnings PresentationEarnings20 slidesJul 26, 2024
Q4 FY24 Earnings PresentationEarnings22 slidesMay 10, 2024
Q4 FY24 Earnings PresentationEarnings23 slidesMay 10, 2024
Nuvama India Conference 2024Conference27 slidesFeb 13, 2024
Q3 FY24 Earnings PresentationEarnings20 slidesJan 22, 2024
Q3 FY2024 Earnings PresentationEarnings19 slidesJan 22, 2024
Nuvama India Conference 2024Conference26 slides2024
Q2 FY24 Earnings PresentationEarnings20 slidesOct 27, 2023
Q2 FY2024 Earnings PresentationEarnings19 slidesOct 27, 2023
Investor Presentation (August 2023)Investor deck8 slidesAugust 2023
Q1 FY2024 Earnings PresentationEarnings17 slidesJul 26, 2023
Q4 FY2023 Earnings PresentationEarnings22 slidesMay 12, 2023
Q4 FY23 Earnings PresentationEarnings21 slidesMay 12, 2023
Q3 FY2023 Earnings PresentationEarnings19 slidesJan 25, 2023
Q3 FY23 Earnings PresentationEarnings20 slidesJan 25, 2023
Q2 FY23 Earnings PresentationEarnings18 slidesNov 4, 2022
Q2 FY2023 Earnings PresentationEarnings19 slidesNov 4, 2022
Shareholder Meeting (August 2022)Shareholder meeting7 slidesAugust 2022
Q1 FY2023 Earnings PresentationEarnings15 slidesJul 29, 2022
Q1 FY23 Earnings PresentationEarnings16 slidesJul 29, 2022
Q1 FY2023 Earnings PresentationEarnings16 slidesJul 29, 2022
Q4 FY2022 Earnings PresentationEarnings16 slidesMay 10, 2022
Q4 FY22 Earnings PresentationEarnings17 slidesMay 10, 2022
Q3 FY2022 Earnings PresentationEarnings14 slidesJan 25, 2022
Q3 FY22 Earnings PresentationEarnings15 slidesJan 25, 2022
40th Annual J.P. Morgan Healthcare Conference (January 2022)Conference22 slidesJan 12, 2022
Q2 FY2022 Earnings PresentationEarnings14 slidesOct 26, 2021
Q2 FY22 Earnings PresentationEarnings15 slidesOct 26, 2021
Q1 FY2022 Earnings PresentationEarnings14 slidesAug 5, 2021
Q1 FY22 Earnings PresentationEarnings15 slidesAug 5, 2021
Shareholder Meeting (August 2021)Shareholder meeting8 slidesAugust 2021
Q4 FY21 Earnings PresentationEarnings16 slidesMay 14, 2021
Q4 FY21 Earnings PresentationEarnings17 slidesMay 14, 2021
Q3 FY2021 Earnings PresentationEarnings15 slidesJan 29, 2021
Q3 FY2021 Earnings PresentationEarnings16 slidesJan 29, 2021
Q2 FY2021 Earnings PresentationEarnings14 slidesNov 6, 2020

This page holds 50 of 81 decks. Open Decks

Open Decks

Financials

Annual, in INR

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue281.6B272.7B255.4B225.6B217.1B191.2B170.8B163.2B151.1B143.3B
Cost of revenue161.3B91.8B90.4B84.6B86.9B75.1B61.5B59.3B55.2B52.2B
Gross profit120.4B180.9B164.9B141.0B130.2B116.1B109.3B103.9B95.9B91.1B
Research and development5.21B14.8B15.2B12.9B2.66B1.33B3.56B3.60B2.70B2.81B
Selling, general and administrative30.9B49.4B44.0B39.2B36.1B33.3B31.0B30.0B28.1B27.5B
Operating income47.1B105.0B94.8B78.0B80.9B73.5B67.1B62.9B59.0B55.3B
Depreciation and amortization12.1B9.95B9.39B11.7B9.90B10.0B11.7B11.0B9.50B8.71B
EBITDA59.2B115.0B104.2B89.7B90.8B83.6B78.8B73.9B68.5B64.0B
Interest expense543.9M620.1M785.1M1.10B911.6M1.46B1.90B1.68B1.14B1.59B
Income before tax52.2B68.0B57.0B40.4B34.8B32.8B21.3B20.6B16.7B12.2B
Income tax13.5B15.3B15.5B12.0B9.34B8.89B6.31B5.70B2.50B1.80B
Net income38.8B52.7B41.2B28.0B25.2B24.0B15.5B15.3B14.1B10.1B
Earnings per share, basic48.0065.2451.0134.6931.1729.7919.1618.9317.5012.50

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents10.2B5.89B6.40B6.28B6.78B7.93B7.42B5.08B8.53B6.10B
Short-term investments90.1B100.2B71.4B56.4B39.5B29.5B2.50B1.01B1.02B37.8M
Receivables60.1B55.1B47.7B40.6B34.2B34.5B38.9B41.5B31.0B25.6B
Inventory66.0B56.4B52.4B51.6B53.5B46.7B43.8B39.6B40.4B34.9B
Current assets241.5B232.9B194.4B172.7B147.1B132.1B117.0B124.3B108.1B88.0B
Property, plant and equipment64.8B59.3B56.8B56.1B56.5B56.7B55.1B58.3B57.3B
Goodwill37.5B32.7B31.1B29.8B31.4B30.1B29.3B28.7B28.1B27.0B
Total assets425.0B373.9B327.2B294.6B271.0B251.5B236.6B239.6B228.6B210.4B
Accounts payable32.3B28.4B24.7B25.3B25.1B20.7B22.8B19.5B21.2B15.7B
Current liabilities70.1B54.8B52.5B51.1B49.1B45.9B43.9B37.7B38.3B33.7B
Long-term debt1.17B119.8M004.16B12.0B23.7B38.3B36.6B36.5B
Total debt6.14B4.39B5.60B8.03B10.6B20.2B31.1B43.2B41.0B41.1B
Total liabilities79.8B61.0B59.2B57.5B59.8B65.7B76.1B86.2B82.8B80.6B
Shareholders' equity344.3B311.9B267.1B234.1B208.4B183.3B157.6B150.1B142.3B125.4B
Shares outstanding808.2M808.2M808.0M807.6M807.4M807.3M807.1M806.8M806.1M805.3M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations41.3B50.0B41.3B32.4B33.3B37.6B30.7B16.9B14.6B23.8B
Capital spending-16.0B-11.6B-13.5B-11.8B-7.01B-8.19B-10.0B-5.27B-8.16B-11.4B
Free cash flow25.3B38.4B27.8B20.5B26.2B29.4B20.7B11.6B6.47B12.5B
Cash from investing-25.3B-36.9B-29.9B-23.9B-18.7B-23.9B1.04B-16.7B-8.54B-13.1B
Cash from financing-12.1B-12.9B-12.0B-9.58B-16.0B-12.4B-29.5B-3.49B-3.85B-13.3B
Dividends paid-12.9B-10.5B-6.86B-4.04B-4.03B-360.0M-5.64B-2.42B-1.61B-1.61B
Share buybacks500.0K400.0K-5.07B-1.33B-360.0M242.0M-1.11B1.20M-10.1B
Change in cash6.89B303.1M-489.9M-967.8M-1.32B505.8M2.34B-3.45B2.43B-2.48B

Open Financials

Filings

FilingDateTypeFiled with
Cipla Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "Q2FY27 Financial Results".Oct 27, 2026ResultsNSE India
Cipla Ltd Press Release Aug 31 2026Aug 31, 2026Operations updateNSE India
Cipla Ltd Press Release Jul 23 2026Jul 23, 2026ResultsNSE India
Press Release May 13 2026May 13, 2026ResultsNSE India
Press Release Jan 23 2026Jan 23, 2026ResultsNSE India
Press Release Oct 30 2025Oct 30, 2025Other filingsNSE India
Press Release Jul 25 2025Jul 25, 2025ResultsNSE India
Press Release May 13 2025May 13, 2025ResultsNSE India
Press Release Jan 28 2025Jan 28, 2025Other filingsNSE India
Press Release Oct 29 2024Oct 29, 2024Other filingsNSE India
All 76 filings
FilingDateTypeFiled with
Press Release Jul 26 2024Jul 26, 2024Other filingsNSE India
Press Release Jun 18 2024Jun 18, 2024Other filingsNSE India
Press Release May 10 2024May 10, 2024Other filingsNSE India
Press Release Mar 26 2024Mar 26, 2024Other filingsNSE India
Press Release Jan 22 2024Jan 22, 2024Other filingsNSE India
Press Release Jan 08 2024Jan 8, 2024Other filingsNSE India
Press Release (Revised) Dec 15 2023Dec 15, 2023Legal or regulatory actionNSE India
Press Release Dec 14 2023Dec 14, 2023Acquisition or disposalNSE India
Cipla Ltd Press Release Dec 10 2023Dec 9, 2023Other filingsNSE India
Press Release Oct 27 2023Oct 27, 2023Other filingsNSE India
Press Release Sep 04 2023Sep 4, 2023Acquisition or disposalNSE India
Press Release Jul 26 2023Jul 26, 2023Other filingsNSE India
Press Release Jul 07 2023Jul 7, 2023Other filingsNSE India
Press Release May 12 2023May 12, 2023Other filingsNSE India
Press Release Jan 25 2023Jan 25, 2023Other filingsNSE India
Cipla Ltd Press Release Jan 18 2023Jan 17, 2023Operations updateNSE India
Press Release Dec 30 2022Dec 30, 2022Other filingsNSE India
Press Release Nov 29 2022Nov 29, 2022Operations updateNSE India
Press Release Nov 04 2022Nov 4, 2022Other filingsNSE India
Press Release Oct 11 2022Oct 11, 2022Operations updateNSE India
Press Release Sep 07 2022Sep 7, 2022Other filingsNSE India
Press Release Jul 29 2022Jul 29, 2022Other filingsNSE India
Press Release Jul 14 2022Jul 14, 2022Acquisition or disposalNSE India
Press Release Jun 27 2022Jun 27, 2022Other filingsNSE India
Press Release Jun 17 2022Jun 17, 2022Other filingsNSE India
Press Release Jun 14 2022Jun 14, 2022Operations updateNSE India
Press Release Jun 02 2022Jun 2, 2022Other filingsNSE India
Press Release May 25 2022May 25, 2022Other filingsNSE India
Press Release May 10 2022May 10, 2022Other filingsNSE India
Press Release Jan 25 2022Jan 25, 2022Other filingsNSE India
Press Release Jan 13 2022Jan 13, 2022Other filingsNSE India
Press Release Dec 28 2021Dec 28, 2021Operations updateNSE India
Press Release Dec 18 2021Dec 18, 2021Other filingsNSE India
Press Release Dec 15 2021Dec 15, 2021Acquisition or disposalNSE India
Press Release Nov 17 2021Nov 17, 2021Operations updateNSE India
Press Release Nov 15 2021Nov 15, 2021Other filingsNSE India
Press Release Oct 26 2021Oct 26, 2021Other filingsNSE India
Press Release Oct 04 2021Oct 4, 2021Other filingsNSE India
Press Release Aug 25 2021Aug 25, 2021Other filingsNSE India
Press Release Aug 12 2021Aug 12, 2021Other filingsNSE India
Press Release Aug 05 2021Aug 5, 2021Other filingsNSE India
Press Release Jun 29 2021Jun 29, 2021Operations updateNSE India
Press Release Jun 23 2021Jun 23, 2021Operations updateNSE India
Press Release Jun 15 2021Jun 15, 2021Other filingsNSE India
Press Release May 24 2021May 24, 2021Other filingsNSE India
Press Release May 20 2021May 20, 2021Operations updateNSE India
Press Release May 14 2021May 14, 2021ResultsNSE India
Press Release May 10 2021May 10, 2021Other filingsNSE India
Press Release May 05 2021May 5, 2021Other filingsNSE India
Press Release Apr 28 2021Apr 28, 2021Other filingsNSE India
Press Release Mar 23 2021Mar 23, 2021Other filingsNSE India
Press Release Mar 18 2021Mar 18, 2021Other filingsNSE India
Press Release Mar 02 2021Mar 2, 2021Operations updateNSE India
Press Release Jan 29 2021Jan 29, 2021Other filingsNSE India
Press Release Jan 27 2021Jan 27, 2021Operations updateNSE India
Press Release Dec 18 2020Dec 18, 2020Other filingsNSE India
Press Release Dec 16 2020Dec 16, 2020Operations updateNSE India
Press Release Dec 11 2020Dec 11, 2020Other filingsNSE India
Press Release Nov 18 2020Nov 18, 2020Operations updateNSE India
Press Release Nov 06 2020Nov 6, 2020Other filingsNSE India
Press Release Oct 28 2020Oct 28, 2020Other filingsNSE India
Press Release Oct 20 2020Oct 20, 2020Operations updateNSE India
Press Release Oct 12 2020Oct 12, 2020Other filingsNSE India
Press Release Sep 25 2020Sep 25, 2020Other filingsNSE India
Press Release Aug 20 2020Aug 20, 2020Other filingsNSE India
Press Release Aug 07 2020Aug 7, 2020ResultsNSE India

Open Filings

Cap table

Built by 6ix from Cipla Ltd’s releases

Common shares
807,870,615
Fully diluted
807,870,615

Fully diluted

LineShares
Common shares807,870,615

Share count over time

CountShares
Nov 22, 2026807,870,615

Open Cap table

Shareholders

HolderSharesValueAs of
Vanguard Total International Stock Index Fund8.44MUS$130MJul 31, 2026
Vanguard Emerging Markets Stock Index Fund8.04MUS$124MJul 31, 2026
iShares Core MSCI Emerging Markets ETF6.2MUS$91.4MMay 31, 2026
iShares MSCI India ETF2.74MUS$40.4MMay 31, 2026
Fidelity SAI Emerging Markets Value Index Fund2.61MUS$40.3MJul 31, 2026
Fidelity SAI Emerging Markets Low Volatility Index Fund1.74MUS$26.8MJul 31, 2026
Emerging Markets Core Equity 2 Portfolio1.55MUS$23.9MJul 31, 2026
iShares MSCI Emerging Markets ex China ETF1.36MUS$20.1MMay 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund1.36MUS$20.9MJul 31, 2026
iShares MSCI Emerging Markets ETF1.34MUS$19.8MMay 31, 2026
Show 50 holders
HolderSharesValueAs of
State Street(R) SPDR(R) Portfolio Emerging Markets ETF1.19MUS$18.5MJun 30, 2026
Fidelity Series Global ex U.S. Index Fund1.01MUS$15.6MJul 31, 2026
iShares MSCI Emerging Markets Min Vol Factor ETF1MUS$14.7MMay 31, 2026
Franklin FTSE India ETF930KUS$14.4MJun 30, 2026
Dimensional Emerging Markets Value Fund812KUS$12.5MJul 31, 2026
iShares Core MSCI Total International Stock ETF719KUS$11.1MJul 31, 2026
Schwab Emerging Markets Equity ETF643KUS$9.48MMay 31, 2026
Avantis Emerging Markets Equity ETF635KUS$9.36MMay 31, 2026
Fidelity Emerging Markets Index Fund620KUS$9.58MJul 31, 2026
WisdomTree India Earnings Fund561KUS$8.69MJun 30, 2026
Vanguard Total World Stock Index Fund469KUS$7.23MJul 31, 2026
Dimensional Emerging Core Equity Market ETF448KUS$6.91MJul 31, 2026
The Emerging Markets Series444KUS$6.84MJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF403KUS$6.23MJul 31, 2026
Nuveen Emerging Markets Equity Index Fund403KUS$6.22MJul 31, 2026
Mercer Emerging Markets Equity Fund379KUS$5.9MJun 30, 2026
Fidelity Total International Index Fund302KUS$4.66MJul 31, 2026
Fidelity Global ex U.S. Index Fund271KUS$4.18MJul 31, 2026
iShares India 50 ETF270KUS$4.18MJun 30, 2026
College Retirement Equities Fund - Total Global Stock Account255KUS$3.96MJun 30, 2026
Siit Emerging Markets Equity Fund216KUS$3.18MMay 31, 2026
Empower Emerging Markets Equity Fund211KUS$3.27MJun 30, 2026
Dimensional World ex. U.S. Core Equity 2 ETF200KUS$3.09MJul 31, 2026
Kotak India Equity Fund199KUS$3.07MJul 31, 2026
iShares MSCI ACWI ETF193KUS$2.98MJul 31, 2026
Tax-Managed International Equity Fund189KUS$2.92MJul 31, 2026
iShares MSCI All Country Asia ex Japan ETF178KUS$2.74MJul 31, 2026
First Trust India NIFTY 50 Equal Weight ETF178KUS$2.75MJun 30, 2026
Fidelity ZERO International Index Fund173KUS$2.67MJul 31, 2026
iShares MSCI ACWI ex U.S. ETF163KUS$2.52MJul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio162KUS$2.5MJun 30, 2026
Fidelity SAI Emerging Markets Index Fund152KUS$2.35MJul 31, 2026
Lazard Emerging Markets Equity Advantage Portfolio151KUS$2.34MJun 30, 2026
iShares Emerging Markets Equity Factor ETF133KUS$1.96MMay 31, 2026
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund131KUS$2.02MJun 30, 2026
Emerging Markets Equity Index Fund123KUS$1.91MJun 30, 2026
Vanguard ESG International Stock ETF117KUS$1.72MMay 31, 2026
iShares MSCI Global Min Vol Factor ETF110KUS$1.63MMay 31, 2026
Invesco RAFI Emerging Markets ETF109KUS$1.68MJul 31, 2026
World ex U.S. Core Equity Portfolio103KUS$1.59MJul 31, 2026

This page holds 50 of 122 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Abhijit JoshiNon-Executive Director · Since at least Nov 6, 2026
Achin GuptaManaging Director & Global Chief Executive Officer · Since at least Sep 4, 2026
Adil ZainulbhaiNon-Executive Director · Since at least Nov 6, 2026
Arun KakatkarGlobal Chief People Officer · Since at least Nov 6, 2026
Balram BhargavaIndependent Director · Since at least Nov 6, 2026
Dinesh JainGlobal Chief Financial Officer · Since at least Nov 6, 2026
Jaideep GogtayGlobal Chief Medical Officer · Since at least Nov 6, 2026
Mandar VaidyaIndependent Director · Since at least Nov 6, 2026
Marc FalkinCEO - North America · Since at least Sep 4, 2026
Maya HariIndependent Director · Since at least Nov 6, 2026
All 19 people
PersonSeat
Meera VanjariChief General Counsel (Global) · Since at least Nov 6, 2026
Paul MillerCEO Cipla South Africa & Regional Head Africa and Access · Since at least Nov 6, 2026
Prabhakaran NairGlobal Chief Manufacturing Officer · Since at least Nov 6, 2026
Rashmi JoshiIndependent Director · Since at least Nov 6, 2026
Sai MungaraGlobal Head Supply Chain · Since at least Nov 6, 2026
Shivam PuriCEO - One India Business · Since at least Nov 6, 2026
Sneha HiranandaniChief Information Officer · Since at least Nov 6, 2026
Sushrut KulkarniGlobal Chief- Integrated Product Development (IPD) · Since at least Nov 6, 2026
Swapn MalpaniCEO – Emerging Markets and Europe · Since at least Nov 6, 2026

Open People

Log in to ask 6ix AI your own questions about Cipla Ltd.